Search

Your search keyword '"Khasanov, N."' showing total 90 results

Search Constraints

Start Over You searched for: Author "Khasanov, N." Remove constraint Author: "Khasanov, N."
90 results on '"Khasanov, N."'

Search Results

1. Alisher Navai about Khoja Ahmad Yassawi and his followers

3. Incidence of familial hypercholesterolemia in patients with early manifestations of coronary artery disease: data from a Russian multicenter study and meta-analysis

6. Influence of hydrochemical indicators on the age and density of bivalve molluscs, spread in the lower reaches of the Zarafshan river

12. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in europe. the ACVC-EAPCI EORP STEMI registry of the european society of cardiology

16. Approaches to the therapy of heart failure with reduced ejection fraction. Resolution of an online meeting of the Volga Federal District experts

21. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

22. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

23. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

26. Left ventricular global function index as a predictor of adverse cardiovascular events in patients with acute coronary syndrome

27. Resolution of an online meeting of the Volga Federal District experts on the EMPEROR-Reduced trial “A new era in the treatment of patients with HF. From EMPA-REG OUTCOME to EMPEROR-Reduced trial”

31. Resolution of the online meeting of Russian experts on the EMPEROR-REDUCED trial

34. Changes in the management of patients with acute coronary syndrome – have the disease outcomes changed?

37. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

38. The Effects of Telmisartan and Its Combinations on Office Blood Pressure: Results of Prospective Observational Study TAINA

40. The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry

41. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

42. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

43. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

45. Bleeding risk factors in patients with acute coronary syndrome: data from observational studies ORACUL II

Catalog

Books, media, physical & digital resources